MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonic epilepsy"

  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    When Jerks and Stumbles Become More Than Just Clumsiness

    D. Desai, A. Shah, S. Udani, K. Desai, S. Desai (Anand, India)

    Objective: To describe a case of a girl with progressive seizures, imbalance and regression due to a rare disorder and discuss the approach to the…
  • 2024 International Congress

    A Poor Prognosis for Acute Post Hypoxic Myoclonus with Status Epilepticus: A Case Report

    A. Kurniadi (Kabupaten Bekasi, Indonesia)

    Objective: This article reviews the diagnosis, management, and prognosis of acute Post Hypoxic Myoclonus (PHM) with myoclonic status (MS) and status epilepticus (SE) based on…
  • 2023 International Congress

    Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry

    S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen (Kuopio, Finland)

    Objective: An objective method is presented for monitoring of positive and negative myoclonus using wearable surface EMG and 3D accelerometry in clinical and home settings.…
  • 2023 International Congress

    Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model

    S. Polet, R. Lambrechts, M. de Koning-Tijssen, O. Sibon, T. de Koning, J. Gorter (Groningen, Netherlands)

    Objective: To determine the effect of conventional anti-epileptic drugs in a North Sea Progressive Myoclonus Epilepsy (NS-PME) Drosophila model. Background: In 2011, Corbett et al.…
  • 2023 International Congress

    Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

    R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)

    Objective: To describe a rare case of NUS1 gene mutation related progressive epilepsy myoclonus ataxia syndrome. Background: Pathogenic variants of NUS1 gene have been associated…
  • 2023 International Congress

    Movement disorders in children with progressive myoclonic epilepsies

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, I. Ben Youssef-Turki (Tunis, Tunisia)

    Objective: To analyze the clinical aspects, radiological features and evolution of myoclonus and other movement disorders (MD) in children with progressive myoclonic epilepsies (PMEs). Background:…
  • 2022 International Congress

    Aberrant visual-related networks in familial cortical myoclonic tremor with epilepsy

    H. Wang, B. Wang, Z. Cen, J. Wang, Y. Zang, D. Yang, Y. Ding, S. Wang, S. Wu, W. Luo (Hangzhou, China)

    Objective: To explore the mechanism of prominent visual-related symptoms and photosensitivity, and to investigate alterations of local brain activity and visual-related networks using resting-state functional magnetic…
  • 2022 International Congress

    NUS1 Mutation Causing Ataxia, Myoclonus, and Progressive Encephalopathy

    B. Barton, M. Rosenbaum (Chicago, USA)

    Objective: Describe a rare cause of progressive myoclonus, ataxia, developmental delay Background: 37-year-old man with normal birth but delays in developmental milestones presented for evaluation…
  • MDS Virtual Congress 2021

    Founder effect in (TTTTA)exp(TTTCA)exp and pure (TTTTA)exp in familial cortical myoclonic tremor with epilepsy type 1-SAMD12 locus

    ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)

    Objective: To detect the founder effect between familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) patients with (TTTTA)exp(TTTCA)exp (exp, expansion) in SAMD12 and healthy controls with…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley